FI951218A0 - Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä - Google Patents

Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä

Info

Publication number
FI951218A0
FI951218A0 FI951218A FI951218A FI951218A0 FI 951218 A0 FI951218 A0 FI 951218A0 FI 951218 A FI951218 A FI 951218A FI 951218 A FI951218 A FI 951218A FI 951218 A0 FI951218 A0 FI 951218A0
Authority
FI
Finland
Prior art keywords
cholesterol
low density
density lipoprotein
total blood
lowering total
Prior art date
Application number
FI951218A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951218A7 (fi
FI951218L (fi
Inventor
Steven L Nissen
Original Assignee
Univ Iowa State Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25484425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI951218(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Iowa State Res Found Inc filed Critical Univ Iowa State Res Found Inc
Publication of FI951218A0 publication Critical patent/FI951218A0/fi
Publication of FI951218A7 publication Critical patent/FI951218A7/fi
Publication of FI951218L publication Critical patent/FI951218L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI951218A 1992-09-16 1993-09-15 Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä FI951218L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94640492A 1992-09-16 1992-09-16
PCT/US1993/008695 WO1994006417A1 (en) 1992-09-16 1993-09-15 Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol

Publications (3)

Publication Number Publication Date
FI951218A0 true FI951218A0 (fi) 1995-03-15
FI951218A7 FI951218A7 (fi) 1995-03-15
FI951218L FI951218L (fi) 1995-03-15

Family

ID=25484425

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951218A FI951218L (fi) 1992-09-16 1993-09-15 Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä

Country Status (12)

Country Link
US (1) US5360613A (show.php)
EP (1) EP0660706B1 (show.php)
JP (1) JP3148243B2 (show.php)
AU (1) AU673002B2 (show.php)
BR (1) BR9307035A (show.php)
CA (1) CA2142314C (show.php)
DE (1) DE69327468T2 (show.php)
ES (1) ES2142353T3 (show.php)
FI (1) FI951218L (show.php)
NO (1) NO951000D0 (show.php)
NZ (1) NZ256300A (show.php)
WO (1) WO1994006417A1 (show.php)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US6103764A (en) * 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
WO2000043017A1 (en) * 1999-01-21 2000-07-27 Steroidogenesis Inhibitors International Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
CN100542525C (zh) * 2001-05-18 2009-09-23 隆萨股份公司 制备3-羟基-3-甲基丁酸钠固体制剂的方法
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040220266A1 (en) * 2002-09-09 2004-11-04 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
US6812249B2 (en) * 2003-03-04 2004-11-02 Sal Abraham Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use
EP1750527A1 (en) * 2004-03-11 2007-02-14 Wiley Organics, Inc. Compositions and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
EP1973426A2 (en) * 2005-11-03 2008-10-01 Southwest Immunology Inc. Compositions for preventing and reducing delayed onset muscle soreness
CA2632262C (en) 2005-12-19 2015-04-07 Abbott Laboratories Method of using .beta.-hydroxy-.beta.-methylbutyrate
US20080200422A1 (en) * 2007-01-09 2008-08-21 Cavener Douglas R Methods for reduction of adipose tissue mass
US9770424B2 (en) 2008-12-09 2017-09-26 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
EP2381784B1 (en) 2008-12-09 2018-07-11 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US11173167B2 (en) 2008-12-09 2021-11-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9539224B2 (en) 2008-12-09 2017-01-10 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9707241B2 (en) 2008-12-09 2017-07-18 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9259430B2 (en) 2008-12-09 2016-02-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US11042605B2 (en) 2009-07-21 2021-06-22 Ccqcc Corp. Method and apparatus for calibration and testing of scientific measurement equipment
US8538727B2 (en) * 2009-07-21 2013-09-17 George S. Cembrowski Method and apparatus for calibration and testing of scientific measurement equipment
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
EP2461704B1 (en) 2010-01-29 2013-10-09 Abbott Laboratories Aseptically packaged nutritional liquids comprising hmb
BR112012017690A2 (pt) 2010-01-29 2015-09-01 Abbott Lab Emulsões nutricionais compreendendo hmb de cálcio
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
PH12014500198A1 (en) * 2011-07-15 2017-02-10 Nusirt Sciences Inc Compositions and methods for modulating metabolic pathways
CN103857390A (zh) * 2011-08-15 2014-06-11 雅培制药有限公司 用于制备hmb及其盐的方法
WO2013067485A1 (en) 2011-11-03 2013-05-10 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
WO2012140276A2 (en) * 2011-11-17 2012-10-18 Lonza Ltd Process for the preparation of 3-hydroxy-3-methylbutyric acid or its calcium salts
AU2013312113B2 (en) 2012-09-10 2018-08-02 Metabolic Technologies, LLC Composition of HMB and ATP and methods of use
WO2015148982A1 (en) 2014-03-27 2015-10-01 Winterfield Roland W Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy
PL3349745T3 (pl) 2015-09-16 2024-05-20 Metabolic Technologies, LLC Kompozycje i sposoby stosowania beta-hydroksy-beta-metylomaślanu (hmb) w celu poprawy regeneracji po urazach tkanek miękkich
US12208073B2 (en) 2015-09-16 2025-01-28 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
CN108473411B (zh) * 2015-11-19 2022-08-12 协和发酵生化株式会社 3-羟基异戊酸的一价阳离子盐的晶体及该晶体的制造方法
BR112018014920A2 (en) 2016-01-21 2018-12-18 Metabolic Technologies, Inc. methods of modulating autophagy, treating or reducing the likelihood of onset of an autophagy-mediated condition, treating, inhibiting, reducing, decreasing, or preventing an age-related disorder, modulating the expression or activity of at least one factor transcription, treatment, prevention, reduction, inhibition or reduction of a pathological condition attributable to a state of nutrient excess, promoting longevity by modulating autophagy, increasing the length of time a mammal can lead a lifestyle active without suffering from conditions associated with aging and extending the health of a mammal.
KR20190028441A (ko) 2016-06-24 2019-03-18 가부시키가이샤 오츠카 세이야쿠 고죠 3-히드록시이소발레르산의 아미노산염의 결정 및 그 제조 방법
PL3528801T3 (pl) 2016-10-21 2025-02-03 Metabolic Technologies, LLC Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) i probiotyków

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629449A (en) * 1968-04-22 1971-12-21 Majid Siddiqi Process of combatting hypercholesterolemia
US4760090A (en) * 1986-03-11 1988-07-26 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to cattle and sheep
US4764531A (en) * 1986-03-11 1988-08-16 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to laying chickens
US5028440A (en) * 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US5087472A (en) * 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US4992470A (en) * 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals

Also Published As

Publication number Publication date
NO951000L (no) 1995-03-15
FI951218A7 (fi) 1995-03-15
EP0660706A1 (en) 1995-07-05
AU673002B2 (en) 1996-10-24
BR9307035A (pt) 1999-06-29
JPH08501777A (ja) 1996-02-27
EP0660706B1 (en) 1999-12-29
NO951000D0 (no) 1995-03-15
CA2142314C (en) 1999-06-01
WO1994006417A1 (en) 1994-03-31
EP0660706A4 (show.php) 1995-07-26
FI951218L (fi) 1995-03-15
JP3148243B2 (ja) 2001-03-19
US5360613A (en) 1994-11-01
AU4922593A (en) 1994-04-12
NZ256300A (en) 1997-06-24
ES2142353T3 (es) 2000-04-16
DE69327468D1 (de) 2000-02-03
DE69327468T2 (de) 2000-05-11
CA2142314A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
FI951218A0 (fi) Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä
KR960703646A (ko) 게임 장치 및 게임의 리플레이 방법(Game Apparatus and Method of Replaying Game)
NO950774D0 (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
FI942763L (fi) Menetelmä ja laite pienitiheyksisen lipoproteiinin suoran määrityksen tekemiseksi
ITMI940903A0 (it) Metodo ed apparecchiatura per registrare un livello di contenuto
FI930008A0 (fi) Menetelmä ja sovitelma kiertovoitelujärjestelmän yhteydessä
DE68925568D1 (de) Laminierter Film und Methode zu dessen Herstellung
DE69314858D1 (de) Reissverschluss und Verfahren zu dessen Herstellung
FI904680A7 (fi) Menetelmä ja laite folioiden "kylmäsyvävetämiseksi"
FI93269B (fi) Menetelmä ja sovitelma kiertovoitelujärjestelmän yhteydessä
PL292307A1 (en) Insecticide and method of obtaining same
FI970098A0 (fi) Menetelmä ja yhdiste hiustenlähdön hoitamiseksi
GB8928940D0 (en) Character information display system of cassette player and method thereof
SE9401739D0 (sv) Metod för resning och nedtagning av tält
SE9304134D0 (sv) Förfarande och anordning vid tät kontaktering av folier
SE9202659D0 (sv) Metod och anordninar foer produktion av kallasfalt
SE9402984D0 (sv) Byggelement och metod för framställning
SE8704743D0 (sv) Metod vid uppvermning och anordning for genomforande av metoden
BR9600881A (pt) Conjunto introdutor de cateter e método de formar o mesmo
SE9101202D0 (sv) Metod och anordning vid blaesterapparat
FI972334A0 (fi) En metod foer arrangering av byggnadens ventilation och byggnadens ventionsarrangemang
SE8900720D0 (sv) Metod och anordning foer maetning av objekttaethet
SE8304173D0 (sv) Princip och metod for metning av niva i vetskor
FI94736B (fi) Menetelmä ja laite puun talteenotossa
SE9200175L (sv) Saett och anlaeggning foer koncentrationsbestaemning